News
Sir Shankar Balasubramanian, co-founder of Cambridge Epigenetix, FRS, FMedSci, Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, said ...
Balasubramanian and chemist David Klenerman, both at the University of Cambridge, founded the start-up Solexa in 1998; in 2006, they released their first commercial genome analyzer, able to ...
“Our sequencing technology works with all sequencers and enhances their accuracy, as opposed to replacing or competing with them,” said Shankar Balasubramanian, founder of Cambridge Epigenetix.
University of Cambridge researchers, led by Professor Sir Shankar Balasubramanian, have outlined a new DNA sequencing method which can detect where and how small molecule drugs interact with the ...
Biography Professor Sir Shankar Balasubramanian MRSC is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge and senior group leader at Cancer Research UK’s Cambridge ...
Cambridge Epigenetix is a spinout of the University of Cambridge that was founded in 2012 by Yerramilli-Rao and Shankar Balasubramanian. The latter is credited with co-inventing the Solexa ...
Sir Shankar Balasubramanian is responsible for a revolution in medicine. The method he invented for reading, at speed, the unique genetic code that makes each one of us who we are, is ten million ...
Quantifying quadruplexes By Tia Ghose Courtesy of Julian Huppert The paper: J.L. Huppert and S. Balasubramanian, "G-quadruplexes in promoters throughout the human genome," Nucleic Acids Res, 35:406–13 ...
This event will involve: i) a keynote lecture from Professor Sir Shankar Balasubramanian, University of Cambridge; ii) a panel discussion on disruptive startups being key to UK economic growth and ii) ...
Sir Shankar Balasubramanian is responsible for a revolution in medicine. The method he invented for reading, at speed, the unique genetic code that makes each one of us who we are, is ten million ...
Professor Shankar Balasubramanian from the University of Cambridge UK, is awarded the 2013 Tetrahedron Prize for his outstanding contributions to nucleic acid chemistry and biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results